Zinc Translocation Causes Hypoglycemia-Induced Neuron Death
نویسنده
چکیده
Hypoglycemia is a common but serious problem among type1 and type 2 diabetic patients receiving intensive treatment with glucose-lowering drugs such as insulin or sulfonylurea. Moderate hypoglycemia is occurring 0.1-0.3 episode/patient per day and is usually corrected by patients themselves or just ignored. However, severe hypoglycemia causes unconsciousness and it may lead to neuronal injury in the cerebral cortex and hippocampus. Hypoglycemic neuronal death is resulted from a cascade of several events after prolonged period of lack of glucose since brain exclusively use glucose (Auer et al., 1984a; Auer and Siesjo, 1993; Auer et al., 1984b). Sustained release of glutamate from presynaptic terminals into the extracellular space and activation of glutamate receptors has been suggested as a necessary upstream event in this neuron death cascade (Auer and Siesjo, 1993; Wieloch, 1985). Also mitochondrial membrane permeability (Friberg et al., 1998), calpain activation (Ferrand-Drake et al., 2003), PARP-1 activation (Suh et al., 2003) and NADPH oxidase activation-induced ROS production (Suh et al., 2007; Suh et al., 2008) have been shown to be possible downstream events. Our lab has undertaken studies to establish whether vesicular zinc release and subsequent zinc translocation into postsynaptic neurons is an important upstream step in this hypoglycemia-induced neuron death process. Using an animal model of insulin-induced hypoglycemia we have shown that: (I) vesicular zinc is released from hippocampal mossy fiber terminals; (II) intracellular zinc accumulation is induced in the hippocampal neurons; (III) neuronal death is reduced by zinc chelation or zinc transporter gene deletion; (IV) PARP-1 activation is reduced by zinc chelation; (V) ROS production is reduced by zinc chelation after hypoglycemia and glucose reperfusion (HG/GR); and (VI) hypothermia prevented hypoglycemia-induced zinc release and neuron death. Together, these results suggest that zinc translocation is an upstream step linking HG/GR to PARP-1 activation, to NADPH oxidase activation and neuronal death in brain regions containing high concentrations of vesicular zinc. Zinc translocation into postsynaptic neurons was also demonstrated in the hippocampal slice model with combined oxygen and glucose deprivation (OGD) where neuronal zinc accumulation into the hippocampal CA1 neurons is blocked by extracellular zinc chelator, CaEDTA (Yin et al., 2002). In addition, hippocampal slices prepared from zinc transporter 3 (ZnT3) knockout mouse, which have little or no vesicular zinc in neuronal terminals, showed no zinc accumulation in post-synaptic neurons following OGD and hypoglycemia (Suh et al., 2008). These hippocampal slice experiments
منابع مشابه
Pyruvate Administration Reduces Recurrent/Moderate Hypoglycemia-Induced Cortical Neuron Death in Diabetic Rats
Recurrent/moderate (R/M) hypoglycemia is common in type 1 diabetes patients. Moderate hypoglycemia is not life-threatening, but if experienced recurrently it may present several clinical complications. Activated PARP-1 consumes cytosolic NAD, and because NAD is required for glycolysis, hypoglycemia-induced PARP-1 activation may render cells unable to use glucose even when glucose availability i...
متن کاملEAAC1 gene deletion alters zinc homeostasis and exacerbates neuronal injury after transient cerebral ischemia.
EAAC1 is a neuronal glutamate and cysteine transporter. EAAC1 uptake of cysteine provides substrate for neuronal glutathione synthesis, which plays a key role in both antioxidant defenses and intracellular zinc binding. Here we evaluated the role of EAAC1 in neuronal resistance to ischemia. EAAC1(-/-) mice subjected to transient cerebral ischemia exhibited twice as much hippocampal neuronal dea...
متن کاملPyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment.
Hypoglycemia-induced brain injury is a significant obstacle to optimal blood glucose control in diabetic patients. Severe hypoglycemia triggers a cascade of events in vulnerable neurons that may culminate in cell death even after glucose normalization. A key event in this cascade is the activation of poly(ADP-ribose) polymerase-1 (PARP-1). Activated PARP-1 consumes cytosolic NAD, and because NA...
متن کاملHypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia.
Severe hypoglycemia causes neuronal death and cognitive impairment. Evidence suggests that hypoglycemic neuronal death involves excitotoxicity and DNA damage. Poly(ADP-ribose) polymerase-1 (PARP-1) normally functions in DNA repair, but promotes cell death when extensively activated by DNA damage. Cortical neuron cultures were subjected to glucose deprivation to assess the role of PARP-1 in hypo...
متن کاملPoly(ADP-ribose) polymerase-1 causes mitochondrial damage and neuron death mediated by Bnip3.
Excessive pathophysiological activity of the nuclear enzyme poly(ADP-ribose) polymerase-1 (PARP1) causes neuron death in brain hypoxia/ischemia by inducing mitochondrial permeability transition and nuclear translocation of apoptosis-inducing factor (AIF). Bcl-2/adenovirus E1B 19 kDa-interacting protein (Bnip3) is a prodeath BH3-only Bcl-2 protein family member that is induced in hypoxia, and ha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2012